Article History
Received: 30 January 2020
Accepted: 31 January 2020
First Online: 3 March 2020
Change Date: 18 March 2020
Change Type: Correction
Change Details: The original version of this article unfortunately contained a mistake.
Compliance with ethical standards
:
: Dr. Arabi is the principal investigator on a clinical trial for lopinavir/ritonavir and interferon in Middle East respiratory syndrome (MERS) and that he was a nonpaid consultant on antiviral active for MERS-coronavirus (CoV) for Gilead Sciences and SAB Biotherapeutics. Dr. Arabi, Murthy, and Prof Webb are investigators on REMAP-CAP and are board members of the International Severe Acute Respiratory and emerging Infection Consortium (ISARIC).
Free to read: This content has been made available to all.